Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacqueline Cloos

Showing results (71-80 of 171) with videos related to

Pageof 18
Sort By:
Nucleosides, Nucleotides & Nucleic Acids|June 19, 2014
Assessment of mercaptopurine (6MP) metabolites and 6MP metabolic key-enzymes in childhood acute lymphoblastic leukemiaAnna Wojtuszkiewicz, Ana Barcelos, Boas Dubbelman, et al.
Journal of Hematology & Oncology|January 15, 2014
Interferon-γ-induced upregulation of immunoproteasome subunit assembly overcomes bortezomib resistance in human hematological cell linesDenise Niewerth, Gertjan J L Kaspers, Yehuda G Assaraf, et al.
Lupus Science & Medicine|January 1, 2016
Pharmacodynamic monitoring of (immuno)proteasome inhibition during bortezomib treatment of a critically ill patient with lupus nephritis and myocarditisKarina A de Groot, Michel Tsang A Sjoe, Denise Niewerth, et al.
Journal of Proteomics|February 9, 2021
The influence of delay in mononuclear cell isolation on acute myeloid leukemia phosphorylation profilesCarolien van Alphen, David G J Cucchi, Jacqueline Cloos, et al.
Therapeutic Drug Monitoring|April 23, 2019
Development and Validation of a Sensitive UHPLC-MS/MS-Based Method for the Analysis of Folylpolyglutamate Synthetase Enzymatic Activity in Peripheral Blood Mononuclear Cells: Application in Rheumatoid Arthritis and Leukemia PatientsIttai B Muller, Marry Lin, Eduard A Struys, et al.
Molecular Pharmacology|April 17, 2014
Antileukemic activity and mechanism of drug resistance to the marine Salinispora tropica proteasome inhibitor salinosporamide A (Marizomib)Denise Niewerth, Gerrit Jansen, Lesley F V Riethoff, et al.
Biochemical Pharmacology|October 27, 2011
Proteasome-based mechanisms of intrinsic and acquired bortezomib resistance in non-small cell lung cancerLeonie H A M de Wilt, Gerrit Jansen, Yehuda G Assaraf, et al.
Blood|June 12, 2012
Cytotoxic effects of bortezomib in myelodysplastic syndrome/acute myeloid leukemia depend on autophagy-mediated lysosomal degradation of TRAF6 and repression of PSMA1Jing Fang, Garrett Rhyasen, Lyndsey Bolanos, et al.
Blood Advances|August 27, 2021
Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classificationInge van der Werf, Anna Wojtuszkiewicz, Manja Meggendorfer, et al.
Arthritis and Rheumatism|February 1, 2006
Acquired resistance to chloroquine in human CEM T cells is mediated by multidrug resistance-associated protein 1 and provokes high levels of cross-resistance to glucocorticoidsRuud Oerlemans, Joost van der Heijden, Josefien Vink, et al.
Pageof 18

Showing results (71-80 of 171) with videos related to

Sort By:
Pageof 18
Nucleosides, Nucleotides & Nucleic Acids|June 19, 2014
Assessment of mercaptopurine (6MP) metabolites and 6MP metabolic key-enzymes in childhood acute lymphoblastic leukemiaAnna Wojtuszkiewicz, Ana Barcelos, Boas Dubbelman, et al.
Journal of Hematology & Oncology|January 15, 2014
Interferon-γ-induced upregulation of immunoproteasome subunit assembly overcomes bortezomib resistance in human hematological cell linesDenise Niewerth, Gertjan J L Kaspers, Yehuda G Assaraf, et al.
Lupus Science & Medicine|January 1, 2016
Pharmacodynamic monitoring of (immuno)proteasome inhibition during bortezomib treatment of a critically ill patient with lupus nephritis and myocarditisKarina A de Groot, Michel Tsang A Sjoe, Denise Niewerth, et al.
Journal of Proteomics|February 9, 2021
The influence of delay in mononuclear cell isolation on acute myeloid leukemia phosphorylation profilesCarolien van Alphen, David G J Cucchi, Jacqueline Cloos, et al.
Therapeutic Drug Monitoring|April 23, 2019
Development and Validation of a Sensitive UHPLC-MS/MS-Based Method for the Analysis of Folylpolyglutamate Synthetase Enzymatic Activity in Peripheral Blood Mononuclear Cells: Application in Rheumatoid Arthritis and Leukemia PatientsIttai B Muller, Marry Lin, Eduard A Struys, et al.
Molecular Pharmacology|April 17, 2014
Antileukemic activity and mechanism of drug resistance to the marine Salinispora tropica proteasome inhibitor salinosporamide A (Marizomib)Denise Niewerth, Gerrit Jansen, Lesley F V Riethoff, et al.
Biochemical Pharmacology|October 27, 2011
Proteasome-based mechanisms of intrinsic and acquired bortezomib resistance in non-small cell lung cancerLeonie H A M de Wilt, Gerrit Jansen, Yehuda G Assaraf, et al.
Blood|June 12, 2012
Cytotoxic effects of bortezomib in myelodysplastic syndrome/acute myeloid leukemia depend on autophagy-mediated lysosomal degradation of TRAF6 and repression of PSMA1Jing Fang, Garrett Rhyasen, Lyndsey Bolanos, et al.
Blood Advances|August 27, 2021
Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classificationInge van der Werf, Anna Wojtuszkiewicz, Manja Meggendorfer, et al.
Arthritis and Rheumatism|February 1, 2006
Acquired resistance to chloroquine in human CEM T cells is mediated by multidrug resistance-associated protein 1 and provokes high levels of cross-resistance to glucocorticoidsRuud Oerlemans, Joost van der Heijden, Josefien Vink, et al.
Pageof 18